Jiudian Pharmaceutical announced that the National Medical Products Administration has approved the market launch of its Traditional Chinese Medicine Category 1.1 innovative drug Jiaoqi Zhitong Gel Patch. The drug is a compound external preparation of traditional Chinese medicine, with the effects of warming the meridians, dispelling cold, promoting blood circulation, and relieving pain. It is mainly used for knee osteoarthritis with cold coagulation and blood stasis syndrome, providing a new treatment option for relevant patients. The company will disclose more details after obtaining the official documents. In the first quarter of 2026, Jiudian Pharmaceutical achieved revenue of 595 million yuan and a net profit attributable to the parent company of 56.74 million yuan.
Hunan Jiudian Pharmaceutical Co LtdCompany's own Category 1.1 innovative drug approved for market, a major R&D milestone.